Telehealth Program Helps Patients Meet Long-Term Weight Loss Goals
AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, today announced the launch of the ORBERA® Coach platform, an on-demand telehealth program that provides virtual aftercare support tailored to meet the needs of patients who undergo the FDA-approved ORBERA® Gastric Balloon procedure. ORBERA® is an incision-less, non-surgical weight loss procedure designed for adult patients suffering from obesity who are not appropriate for or considering invasive surgery but for whom diet, exercise and pharmaceutical interventions have not been effective.
ORBERA® Coach is a telehealth aftercare program that allows patients to access exercise, nutrition, and other coaching resources via on demand interaction with registered dietitians trained on the ORBERA® procedure during the 12 months following placement of the ORBERA® gastric balloon. ORBERA® Coach patients can interact anytime, anywhere via face-to-face live video conferencing, including one-to-one, group and webcast scheduled or on-demand. Zillion’s technology also facilitates group discussion sessions, weight loss tracking, a personal journal to monitor and reflect on progress, a collection of recipes and meal plans geared toward healthy eating and a health and wellness content library. ORBERA® Coach provides significant data for the physician to assist in managing patients who have undergone an ORBERA® procedure.
“Minnesota Gastroenterology has had a Weight Management & Nutrition Program for the past several years. What we are excited to see with ORBERA® Coach is that it includes much of what our program offers but at a lower cost and with much greater flexibility in patient scheduling,” said David Feldshon, M.D., Minnesota Gastroenterology, P.A. “Educational modules are now immediately available to patients to review at their leisure and dietary recommendations are tailored specifically to the balloon procedure. With an electronic database that makes patient follow up much easier, ORBERA® Coach should be a valuable tool to accompany placement of the gastric balloon for any practice.”
To date, more than 220,000 of the ORBERA® balloons have been distributed in over 80 countries with approximately 230 published papers documenting its clinical results. For additional information regarding ORBERA®, please visit orbera.com.
ORBERA® is an incision-less, non-surgical weight loss solution designed for adult patients suffering from obesity, who are not appropriate for or considering invasive surgery, but for whom diet and exercise or pharmaceutical interventions have not worked.
In a non-surgical (endoscopic) procedure done under a mild sedative, the thin and deflated ORBERA® balloon is placed into the stomach. It is then filled with saline until it’s about the size of a grapefruit. The procedure typically takes about 20 to 30 minutes and the patient can generally go home the same day. At six months, through another non-surgical procedure done under a mild sedative, the ORBERA® balloon is deflated and then removed.
Once the balloon is in place, the patient receives an individually tailored support program through the ORBERA® Managed Weight Loss System team of experts – which may include a dietician, psychologist and exercise physiologist – to help keep them motivated, coordinate their program and help them work through weight loss barriers to meet their long-term weight loss goals. Coaching takes place over 12 months, even though the balloon is removed after six months. The program is designed to help the patient develop sustainable, healthy habits that will help keep weight off over time.
For more than 20 years, the global medical community has been using intragastric balloons from the makers of ORBERA® to help thousands of people lose weight. For full safety information please visit orbera.com/dfu, talk with your doctor, or call Apollo Customer Support at 1-855-MYORBERA.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is revolutionizing the treatment of obesity and other gastrointestinal disorders by developing less invasive solutions for a whole new group of patients not seeking treatment today. Apollo is a global innovator pushing boundaries to bring new technologies and innovative products to markets in over 80 countries today. In particular, Apollo’s bariatric products fill the gap between non-surgical weight loss solutions and invasive surgeries, allowing physicians to do more for those patients who require more than drug therapy and dietary advice. For more information regarding Apollo Endosurgery, go to: apolloendo.com.